(Q54359918)

English

Escheriosome mediated cytosolic delivery of Candida albicans cytosolic proteins induces enhanced cytotoxic T lymphocyte response and protective immunity.

scientific article published on 7 June 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21645572

Escheriosome mediated cytosolic delivery of Candida albicans cytosolic proteins induces enhanced cytotoxic T lymphocyte response and protective immunity. (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21645572

0 references

0 references

Candida albicans

1 reference

based on heuristic

inferred from title

author name string

A Chauhan

1

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21645572

Z Swaleha

2

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21645572

N Ahmad

3

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21645572

M Farazuddin

4

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21645572

A Vasco

5

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21645572

M Abida

6

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21645572

Owais Mohammad

7

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21645572

language of work or name

0 references

publication date

7 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21645572

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21645572

29

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21645572

33

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21645572

5424-5433

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21645572

Invasive candida infections--evolution of a fungal pathogen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.066

7 January 2021

Fungal infections in patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.066

7 January 2021

Impact of air filtration on nosocomial Aspergillus infections. Unique risk of bone marrow transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.066

7 January 2021

Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.066

7 January 2021

Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis. Disseminated versus single-organ infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.066

7 January 2021

The T cell response against fungal infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.066

7 January 2021

Immunity to Candida albicans: Th1, Th2 cells and beyond.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.066

7 January 2021

Chronic mucocutaneous candidiasis. I. Altered antigen-stimulated IL-2, IL-4, IL-6 and interferon-gamma (IFN-gamma) production

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.066

7 January 2021

Allergenicity of acid protease secreted by Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.066

7 January 2021

The role of cell-mediated immunity in candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.066

7 January 2021

A TH1-TH2-like switch in candidiasis: new perspectives for therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.066

7 January 2021

The dendritic cell system and its role in immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.066

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.066

7 January 2021

The basis for the immunoregulatory role of macrophages and other accessory cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.066

7 January 2021

Antigen presentation pathways to class I and class II MHC-restricted T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.066

7 January 2021

Susceptibility of beta 2-microglobulin-deficient mice to Trypanosoma cruzi infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.066

7 January 2021

The immunobiology of toxoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.066

7 January 2021

Antigen entrapped in the escheriosomes leads to the generation of CD4+ helper and CD8+ cytotoxic T cell response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.066

7 January 2021

Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.066

7 January 2021

Establishment of resistance to Leishmania major infection in susceptible BALB/c mice requires parasite-specific CD8+ T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.066

7 January 2021

Roles of alpha beta and gamma delta T cell subsets in viral immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.066

7 January 2021

Use of reconstituted influenza virus virosomes as an immunopotentiating delivery system for a peptide-based vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.066

7 January 2021

pH sensitive liposomes provide an efficient means of sensitizing target cells to class I restricted CTL recognition of a soluble protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.066

7 January 2021

Immunostimulatory and antigen delivery properties of liposomes made up of total polar lipids from non-pathogenic bacteria leads to efficient induction of both innate and adaptive immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.066

7 January 2021

Leptosome-entrapped leptospiral antigens conferred significant higher levels of protection than those entrapped with PC-liposomes in a hamster model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.066

7 January 2021

Measurement of protein using bicinchoninic acid

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.066

7 January 2021

B cell knockout mice are resistant to mucosal and systemic candidiasis of endogenous origin but susceptible to experimental systemic candidiasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.066

7 January 2021

IFN-gamma-independent IgG2a production in mice infected with viruses and parasites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.066

7 January 2021

Antiviral T-cell-independent type 2 antibody responses induced in vivo in the absence of T and NK cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.066

7 January 2021

Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.066

7 January 2021

Immunogenicity and protective efficacy of GroEL (hsp60) of Streptococcus pneumoniae against lethal infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.066

7 January 2021

Diagnosis of invasive candidiasis by a dot immunobinding assay for Candida antigen detection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.066

7 January 2021

based on heuristic

inferred from DOI database lookup

Early differential molecular response of a macrophage cell line to yeast and hyphal forms of Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.066

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2011.05.066

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21645572

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21645572

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54359918&oldid=1382137004"